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Appendix
Study Cores: Institution (Core Director)
Data Coordination Center and Surgical Core: Baylor
College of Medicine (J. S. Coselli, Study Principal Investi-
gator)
Marfan Diagnostic Core: Johns Hopkins Hospital (H.
C. Dietz)
ImagingCore:Mayo Clinic, Rochester (H. M. Connolly)
Genetic Repository: University of Texas Medical
School at Houston (D. M. Milewicz)
Participating Study Sites: Institution (Site Principal
Investigator, Number of Patients Enrolled)
Argentina: Institute of Cardiology and Cardiovascular
Surgery—Favaloro Foundation (R. R. Favaloro, 10 pa-
tients).
Canada:University of Ottawa Heart Institute (K-L. Chan,
1 patient).
Germany: Hannover Medical School (A. Haverich, 5 pa-
tients); University Clinic of Schleswig-Holstein (H. H. Si-
evers, 6 patients); University of Leipzig (F. W. Mohr, 14
patients).
Netherlands: Leiden University Medical Center (M. I. M.
Versteegh, 1 patient).
USA: Baylor College of Medicine (J. S. Coselli, 8 pa-
tients); Central Maine Heart and Vascular Institute (R. P. Co-
chran, C. Frumiento, 1 patient); Johns Hopkins Hospital (V.
L. Gott, L. A. Vricella, 16 patients); Loyola University Med-
ical Center (J. P. Schwartz, 3 patients); Mayo Clinic, Roches-
ter (T. M. Sundt III, 21 patients); Missouri Baptist Medical
Center (N. T. Kouchoukos, 5 patients); Montefiore Medical
Center (A. DeAnda, 2 patients); New York Presbyterian–
Cornell Hospital (L. N. Girardi, 7 patients); Northwestern
University Feinberg School of Medicine (T. G. Gleason, C.
Malaisrie, 2 patients); Stanford University (D. C. Miller, 19
patients); University of Pennsylvania (J. E. Bavaria, 19 pa-
tients); Washington University (M. R. Moon, 11 patients).
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Dr Alan D. Hilgenberg (Boston, Mass). Dr Coselli, congratula-
tions to you and your colleagues for designing and implementing this
very important study. The presentation is a report of the current prac-
tice of aortic root repair in patients with MFS from centers in EuropeThe Journal of Thoracic and C23. Svensson LG, Deglurkar I, Ung J, Pettersson G, Gillinov AM,
D’Agostino RS, et al. Aortic valve repair and root preservation by remodel-
ing, reimplantation, and tailoring: technical aspects and early outcome. J
Card Surg. 2007;22:473-9.
24. Kallenbach K, Baraki H, Khaladj N, Kamiya H, Hagl C, Haverich A, et al. Aortic
valve-sparing operation in Marfan syndrome: what do we know after a decade?
Ann Thorac Surg. 2007;83:S764-8.
25. Settepani F, Szeto WY, Pacini D, De Paulis R, Chiariello L, Di Bartolomeo R,
et al. Reimplantation valve-sparing aortic root replacement in Marfan syndrome
using the Valsalva conduit: an intercontinental multicenter study. Ann Thorac
Surg. 2007;83:S769-73.
and North and South America. First of all, it is remarkable that there
was no 30–day mortality in 151 patients, attesting to the safety of
these complex surgical procedures. Seventy percent of the operations
were valve-sparing, all but two of them were of the reimplantation
type, and about two thirds included repair with sinuses.
The patients undergoing AVR were different from those under-
going AVS in several important characteristics. They were older,
they had more preoperative aortic regurgitation, and they under-
went more nonelective operations. These factors probably will af-
fect the long–term results in addition to the presence of
a mechanical valve when comparisons with the outcomes of
AVS patients are made.
The most important information from this study will come from
the years of follow-up data that we hope you will accumulate. The
late results of composite valve graft replacement in patients with
MFS have been reported at least a couple of times in the last sev-
eral years. Survival at 10 years of 75% was reported by Gott in the
New England Journal of Medicine study in 1999. More recent data
from Hopkins presented at the Society of Thoracic Surgeons meet-
ing in 2008 by Cameron had an 85% survival at 10 years. Al-
though these results are good, I suspect that the late results in
terms of survival and freedom from thromboembolism in the
AVS group will be even better in this study. However, how dura-
ble will the AVS operations be in terms of avoiding late operation
for aortic regurgitation? David and Feindel reported freedom from
moderate or severe aortic insufficiency in reimplantation proce-
dures to be 94% at 10 years, and in their studies, MFS was not
a risk factor for late aortic insufficiency. This study should be
able to show whether other surgeons throughout the world can
achieve similar results. I hope that you will keep gathering this im-
portant follow-up data.
I have a couple of questions. Have the participating centers
agreed to include their entire experience with consecutive MFS
patients, and if not, do you think this will make a difference in
the outcomes?
Dr Coselli. They have agreed, and I do believe that not enrolling
consecutive patients would affect the results. The intent has been
that once investigators agreed to participate in the study, they
would recruit and screen consecutive patients. I believe that, so
far, compliance has been very good and consecutive patients
have been screened.
Dr Hilgenberg. I think that would be important. I am assuming
that AVS repair is the preferred operation in all of the centers. What
are the common reasons that valves were replaced, if you know,
and were there situations in which valves might have been spared
if the patient had been referred earlier for surgery?ardiovascular Surgery c Volume 137, Number 5 1131
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decision as to which operation to perform was ultimately made at
the time of surgery; the decision to replace the valve was made
by the surgeon, and it primarily revolved around anatomic features
that the surgeons, who are all well-versed in valve-sparing tech-
niques, believed would compromise the durability of a valve-spar-
ing repair.
There were also some patients whose primary concern was that
they did not want to have a second procedure and did not want to
subject themselves to the risks of the potential lack of durability
of the procedure; these patients selected having a mechanical valve
at the outset.
Dr Hilgenberg. David and Feindel perform cusp repair fre-
quently in these operations, and I think it would be of interest to
the audience to know whether cusp repair was used often or rarely
in this series of patients.
Dr Coselli. In this series of patients, relatively rarely; only 17%
of the patients had cusp repair.
Dr Hilgenberg. One final comment: I am sitting here with my
colleague, Cary Akins, who formulates the reporting of valve-re-
lated complications, and I think the re-exploration for bleeding in
this series really does not belong in the valve-related complications.
That is a surgical complication, not necessarily valve-related, I
believe.
Dr Tirone E. David (Toronto, Ontario, Canada). I am sorry
that I am not participating in this study. I think it is important to
have information regarding the aortic cusps in this database. In1132 The Journal of Thoracic and Cardiovascular Sumy experience with AVS procedures during the past 19 years,
what determines whether a valve can be spared or not is the quality
of the aortic cusps. In at least half of my patients with MFS, I had to
repair the cusps to spare the valve. In other words, these patients
had premature cusp degeneration just as in mitral valve prolapse.
Unless you do something with the cusps, I am surprised that you
ended up with no aortic insufficiency. Do you have data on how
many cusps were abnormal?
Dr Coselli. In the way you describe it, no.
Dr David. I propose that you add this to the database. We find it
the single most important determinant of feasibility of repairing
these valves. Cusps with large stress fenestrations, overstretched
and thinned out, should not be preserved, and AVR probably re-
sults in better outcomes.
Dr Coselli. Dr David, thank you for your comments and thank
you for your immense contribution and pioneering work in this
area. All of the centers that participated involved surgeons who
are well-versed in the techniques and carry on a practice that allows
them to very reliably carry out AVS procedures; I believe that the
results, with no deaths, no strokes, and no moderate or severe aortic
valve regurgitation in the early postoperative period, confirm their
levels of expertise. I think it would be challenging for this type of
registry—which already collects an immense amount of data from
very diverse institutions across the globe—to accumulate the kind
of detailed information on the leaflets that a single surgeon and
a single center can. But I appreciate the insight, and ideally we
can incorporate that.rgery c May 2009
